The FDA is reviewing the first mRNA flu vaccine for adults 50 and older. Learn how this technology could lead to faster and ...

Research into areas like cancer could become collateral damage of a broader anti-mRNA push, according to a new study.

BioNTech envisioned the site making hundreds of millions of vaccines a year, but has since shifted its pipeline to other ...

The Australian man reportedly had the vaccine synthesised and administered to his dog under the guidance of qualified ...

Broader biotech positioning aligns with movements tracked across the nasdaq ecosystem.

Russia announces its first personalised mRNA-based cancer vaccine, Enteromix, offering targeted treatment amid a global race ...

In the closing of the recent trading day, Moderna (MRNA) stood at $49.2, denoting a -1.66% move from the preceding trading ...

An Australian man used AI and expert support to create a personalised cancer vaccine for his dog. The treatment showed promise, while experts urged caution.

OpEd: A CFO making unilateral decisions about academic programs without input from faculty is not nimbleness or good business ...

The Health Care Select Sector SPDR Fund (XLV) declined 5.29% in the first quarter of 2026, it slightly underperformed the ...

More than 60 years after its discovery, scientists are still learning surprising ways DNA stores and translates instructions ...

Technologies for the development of new RNA treatments and gene therapy are marking new milestones in Italy, with the ...